GlassScriptPhysician profile
Aarah D Ramon
NPI 1720502727
$1,764.71
in general payments reported to CMS, 2019-2025
12 companies · $422 in 2025
The $422 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $199 · 2023: $687 · 2024: $457 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,565.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,024.02 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $392.97 | 2023-2025 | Mounjaro, Zepbound |
| Corcept Therapeutics | $101.90 | 2023-2025 | Korlym |
| Shield Therapeutics INC | $80.71 | 2023-2025 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $40.39 | 2023 | |
| Glaxosmithkline, LLC. | $21.90 | 2024 | Trelegy Ellipta, Arexvy |
| Sanofi-Aventis U.S. LLC | $20.81 | 2025 | |
| Pfizer INC. | $19.60 | 2025 | |
| Nevro Corp. | $17.52 | 2023 | Senza |
| Phathom Pharmaceuticals, INC. | $16.76 | 2025 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $14.45 | 2022 | |
| Amgen INC. | $13.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aarah Ramon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.